ASK CNAO IF YOUR CASE CAN BE TREATED WITH HADRONTHERAPY
Find out which tumours can be effectively treated applying hadrontherapy. Send your clinical documentation for a preliminary evaluation.
RISKS OF DEVELOPING A SECONDARY TUMOUR ARE SIGNIFICANTLY LOWER WITH HADRONTHERAPY THAN WITH RADIOTHERAPY
Unlike radiotherapy, that uses X rays, hadrontherapy uses carbon ions and protons. In this way, tumours can be accurately 'attacked' and thus healthy tissues around the target hit are not affected and there is less chance that secondary tumours appear.
SOME PAEDIATRIC TUMOURS CAN BE TREATED WITH HADRONTHERAPY
The advantages? Only the tumour is 'hit' and surrounding tissues are not damaged and the risk of developing radiation-induced secondary tumours is drastically reduced.
AT CNAO, TUMOUR RESEARCH TRAVELS AT 200 THOUSAND KM/SEC
At CNAO, scientific progress, which is the main pillar for any medical innovation, is moving at full speed.
Discover the activities of the Center through CNAO VIRTUAL TOUR. Videos, interviews,
3D images and
WE ARE BUILDING THE UNIQUE CENTER IN THE WORLD WITH PROTONS, CARBON IONS, OTHER IONIC SPECIES AND BNCT
TO FIGHT THE MOST DIFFICULT TUMOURS
CNAO PRESENTS PATIENT'S COURSE THORACO-ABDOMINAL AND PELVIC DISTRICT PATHOLOGIES
The video has the didactic purpose of recounting one of the patient's cure courses within the CNAO center
Join the 3rd Specialized Course on Clinical Aspects of Heavy Ion Therapy Research
The school is primarily intended for medical students specialised in oncology as well as clinicians of all levels in radiotherapy and particle therapy.
The online course will be delivered by over 35 world leaders in the field and will focus on head and neck, sarcoma, prostate, liver and pancreas, organ motion, treatment planning, re-irradiation, gynae and rare indications, innovative methods, present and future clinical trials and radiobiology.
HOPE FOR SOME INOPERABLE OR RADIO-RESISTANT TUMOURS
READ THE MOST BEAUTIFUL TESTIMONIALS
"I discovered that I had an inoperable tumour when I was 9 months pregnant. Thanks to CNAO, today my 3-year old daughter and I are both fine."
DISCOVER THE EDUCATIONAL VIDEO "THE PARTICLE TRAVEL"
REALIZED BY IED FOR CNAO
The video shows the particle travel from the synchrotron, where it is born and accelerated, to the treatment rooms and finally act selectively on the tumor lesion.
The video has been realized by the students of the CG Animation course of the European Institute of Design in Milan. Professor Ugo Amaldi, President emeritus of TERA Foundation, and Gabriella Greison, physicist, writer and theatrical performer, have given their voices to this charity project.
Twenty years of CNAO
The CNAO's Synchrotron
Treating tumours applying hadrontherapy requires a complex particle accelerator: an 80-metre, Ø25 ring connected to the CNAO treatment rooms.
What are the pathologies that can be treated?
Hadrontherapy is a form of radiotherapy to treat and cure tumours that are often inoperable or resistant to traditional radiotherapy treatments. Find out which ones can be treated.
Service charter, reception facilities, contact info of the Public Relations Office. Here you will find everything patients should know
The CNAO treatment process
From the request for evaluation to the follow-up. Here are all the stages of an Hadrontherapy treatment process at the CNAO Foundation.
AGAINST RADIO-RESISTANT AND INOPERABLE TUMORS
IN PAVIA, THE NATIONAL CENTER OF ONCOLOGICAL HADRONTHERAPY.
BOOK A GUIDED TOUR TO CNAO.
Would you like to know the facilities and understand how the CNAO's particle accelerator works? Register for a guided tour. Science belongs to all of us.
The National Center for Oncological Hadrontherapy is the only centre in Italy that uses hadrontherapy with both protons and carbon ions to treat tumours. There are only 6 facilities around the world that can do this, and CNAO is one of them. The Center is based in Pavia, only half an hour away from Milan.
Hadrontherapy is an advanced way of radiotherapy that uses protons and carbon ions instead of X-rays to attack tumour cells. These particles are very heavier and have more energy than electrons and, consequently, they are even more effective to treat some kinds of tumours. Hadrontherapy is particularly suited to treat radio-resistant tumours- those tumours that do not respond to the X-rays used by traditional radiotherapy- or surgically inoperable tumours.
Hadrontherapy is included in the list of treatments covered by the Italian National Health Service since 1 January 2014. Some of the main advantages of this treatment are:
- tumours that are located in particularly difficult locations can be treated;
- it is a highly precise method that targets the affected while sparing surrounding healthy tissue.
In addition to actively dealing with hadrontherapy treatments, CNAO is also a Research and Development Centre whose activities range from radiobiological to translational clinical research, aimed at continuously stepping up the fight against cancer.